1
|
Melcher C, Gottschalk O, Mazoochian F, Pieper K, Wegener V, Pellengahr CS, Teske W, Wegener B. A new minimal-invasive approach for total hip replacement in sheep. Technol Health Care 2023; 31:1867-1874. [PMID: 37125586 DOI: 10.3233/thc-220805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
BACKGROUND Over the last 50 years arthroplasty became the gold-standard treatment for disabling conditions of the coxofemoral joint. Variations of anterior, lateral, and dorsal incision have been applied, but as each approach requires the incision and reflection of various muscles to gain adequate exposure of the joint results are still controversial. OBJECTIVE The purpose of this study was to develop a minimal-invasive, tissue-sparing approach in sheep with reduced risks in animal testing. METHODS 12 mature sheep underwent hip surgery as part of a study to evaluate a hip resurfacing system. In line with the preliminary cadaveric tests a modified, minimal-invasive, musclepreserving surgical approach was sought after. RESULTS We developed a surgical approach to the coxofemoral joint in sheep using only blunt tissue dissection after skin incision without any limitations in joint exposure or increased blood loss/duration of surgery. CONCLUSION Even though limitations occur and femoral orientation in sheep differs from man, joint forces have similar relative directions to the bone with similar bony and vascular anatomy. Therefore, this minimal-invasive muscle preserving approach might be a safe and comparable alternative in still inevitable animal testing.
Collapse
Affiliation(s)
- Carolin Melcher
- Department of Spine Surgery and Scoliosis Center, Schön Klinik Neustadt in Holstein, Neustadt, Germany
- Musculoskeletal University Center, Ludwig Maximilian University of Munich, Munich, Germany
- Department of Spine Surgery and Scoliosis Center, Schön Klinik Neustadt in Holstein, Neustadt, Germany
| | - Oliver Gottschalk
- Department of Foot and Ankle Surgery, Schön Klinik München Harlaching, Munich, Germany
- Department of Spine Surgery and Scoliosis Center, Schön Klinik Neustadt in Holstein, Neustadt, Germany
| | - Farhad Mazoochian
- Department of Foot and Ankle Surgery, Schön Klinik München Harlaching, Munich, Germany
| | - Korbinian Pieper
- Clinic of Veterinary Surgery, Ludwig Maximilian University of Munich, Munich, Germany
| | | | | | | | - Bernd Wegener
- Musculoskeletal University Center, Ludwig Maximilian University of Munich, Munich, Germany
| |
Collapse
|
2
|
Eichenbaum G, Wilsey JT, Fessel G, Qiu QQ, Perkins L, Hasgall P, Monnot A, More SL, Egnot N, Sague J, Marcello S, Connor K, Scutti J, Christian WV, Coplan PM, Wright J, Hastings B, Katz LB, Vreeke M, Calistri-Yeh M, Faiola B, Purushothaman B, Nevelos J, Bashiri M, Christensen JB, Kovochich M, Unice K. An integrated benefit-risk assessment of cobalt-containing alloys used in medical devices: Implications for regulatory requirements in the European Union. Regul Toxicol Pharmacol 2021; 125:105004. [PMID: 34256083 DOI: 10.1016/j.yrtph.2021.105004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 05/27/2021] [Accepted: 07/09/2021] [Indexed: 11/15/2022]
Abstract
In 2017, the European Union (EU) Committee for Risk Assessment (RAC) recommended the classification of metallic cobalt (Co) as Category 1B with respect to its carcinogenic and reproductive hazard potential and Category 2 for mutagenicity but did not evaluate the relevance of these classifications for patients exposed to Co-containing alloys (CoCA) used in medical devices. CoCA are inherently different materials from Co metal from a toxicological perspective and thus require a separate assessment. CoCA are biocompatible materials with a unique combination of properties including strength, durability, and a long history of safe use that make them uniquely suited for use in a wide-range of medical devices. Assessments were performed on relevant preclinical and clinical carcinogenicity and reproductive toxicity data for Co and CoCA to meet the requirements under the EU Medical Device Regulation triggered by the ECHA re-classification (adopted in October 2019 under the 14th Adaptation to Technical Progress to CLP) and to address their relevance to patient safety. The objective of this review is to present an integrated overview of these assessments, a benefit-risk assessment and an examination of potential alternative materials. The data support the conclusion that the exposure to CoCA in medical devices via clinically relevant routes does not represent a hazard for carcinogenicity or reproductive toxicity. Additionally, the risk for the adverse effects that are known to occur with elevated Co concentrations (e.g., cardiomyopathy) are very low for CoCA implant devices (infrequent reports often reflecting a unique catastrophic failure event out of millions of patients) and negligible for CoCA non-implant devices (not measurable/no case reports). In conclusion, the favorable benefit-risk profile also in relation to possible alternatives presented herein strongly support continued use of CoCA in medical devices.
Collapse
Affiliation(s)
- Gary Eichenbaum
- Johnson & Johnson, 410 George St, New Brunswick, NJ, 08901, USA
| | - Jared T Wilsey
- Smith & Nephew, 1450 E Brooks Rd, Memphis, TN, 38116, USA
| | - Gion Fessel
- Smith & Nephew, Oberneuhofstasse 10D, 6340, Baar, Switzerland
| | - Qing-Qing Qiu
- Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA
| | - Laura Perkins
- Abbott Vascular, 3200 Lakeside Dr, Santa Clara, CA, 95054, USA
| | | | - Andrew Monnot
- Cardno ChemRisk, 235 Pine Street Suite 2300, San Francisco, CA, 94104, USA
| | - Sharlee L More
- Cardno ChemRisk, 6720 S Macadam Ave Suite 150, Portland, OR, 97219, USA
| | - Natalie Egnot
- Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA, 15222, USA
| | - Jorge Sague
- Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA
| | | | - Kevin Connor
- Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA
| | - James Scutti
- Boston Scientific, 100 Boston Scientific Way, Marlborough, MA, 01752, USA
| | | | - Paul M Coplan
- Johnson & Johnson, 410 George St, New Brunswick, NJ, 08901, USA; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 19104, USA
| | - John Wright
- Johnson & Johnson, 410 George St, New Brunswick, NJ, 08901, USA
| | - Bob Hastings
- Johnson & Johnson, 410 George St, New Brunswick, NJ, 08901, USA
| | - Laurence B Katz
- LifeScan Global Corporation, 20 Valley Stream Parkway, Malvern, PA, 19355, USA
| | - Mark Vreeke
- Edwards Lifesciences, One Edwards Way, Irvine, CA, 92614, USA
| | | | - Brenda Faiola
- Becton Dickinson, 1 Becton Drive, Franklin Lakes, NJ, 07417, USA; Rho, Inc., 2635 E NC Hwy 54, Durham, NC, 27713, USA
| | | | - Jim Nevelos
- Stryker, 2825 Airview Boulevard, Kalamazoo, MI, 49002, USA
| | - Mehran Bashiri
- Stryker Neurovascular, 47900 Bayside Parkway, Fremont, CA, 94538, USA
| | | | - Michael Kovochich
- Cardno ChemRisk, 30 North LaSalle St Suite 3910, Chicago, Illinois, 60602-2590, USA
| | - Kenneth Unice
- Cardno ChemRisk, 20 Stanwix Street Suite 505, Pittsburgh, PA, 15222, USA.
| |
Collapse
|
3
|
Carcinogenic hazard assessment of cobalt-containing alloys in medical devices: Review of in vivo studies. Regul Toxicol Pharmacol 2021; 122:104910. [DOI: 10.1016/j.yrtph.2021.104910] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 02/03/2021] [Accepted: 02/24/2021] [Indexed: 11/19/2022]
|
4
|
Gibon E, Amanatullah DF, Loi F, Pajarinen J, Nabeshima A, Yao Z, Hamadouche M, Goodman SB. The biological response to orthopaedic implants for joint replacement: Part I: Metals. J Biomed Mater Res B Appl Biomater 2016; 105:2162-2173. [PMID: 27328111 DOI: 10.1002/jbm.b.33734] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2015] [Revised: 04/19/2016] [Accepted: 06/01/2016] [Indexed: 12/12/2022]
Abstract
Joint replacement is a commonly performed, highly successful orthopaedic procedure, for which surgeons have a large choice of different materials and implant designs. The materials used for joint replacement must be both biologically acceptable to minimize adverse local tissue reactions, and robust enough to support weight bearing during common activities of daily living. Modern joint replacements are made from metals and their alloys, polymers, ceramics, and composites. This review focuses on the biological response to the different biomaterials used for joint replacement. In general, modern materials for joint replacement are well tolerated by the body as long as they are in bulk (rather than in particulate or ionic) form, are mechanically stable and noninfected. If the latter conditions are not met, the prosthesis will be associated with an acute/chronic inflammatory reaction, peri-prosthetic osteolysis, loosening and failure. This article (Part 1 of 2) is dedicated to the use of metallic devices in orthopaedic surgery including the associated biological response to metallic byproducts is a review of the basic science literature regarding this topic. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 2162-2173, 2017.
Collapse
Affiliation(s)
- Emmanuel Gibon
- Department of Orthopaedic Surgery, Stanford University, Stanford, California.,Laboratoire de Biomécanique et Biomatériaux Ostéo-Articulaires - UMR CNRS 7052, Faculté de Médecine - Université Paris7, Paris, France.,Department of Orthopaedic Surgery, Hopital Cochin, APHP, Université Paris5, Paris, France
| | - Derek F Amanatullah
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| | - Florence Loi
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| | - Jukka Pajarinen
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| | - Akira Nabeshima
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| | - Zhenyu Yao
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| | - Moussa Hamadouche
- Department of Orthopaedic Surgery, Hopital Cochin, APHP, Université Paris5, Paris, France
| | - Stuart B Goodman
- Department of Orthopaedic Surgery, Stanford University, Stanford, California
| |
Collapse
|
5
|
Madl AK, Kovochich M, Liong M, Finley BL, Paustenbach DJ, Oberdörster G. Toxicology of wear particles of cobalt-chromium alloy metal-on-metal hip implants Part II: Importance of physicochemical properties and dose in animal and in vitro studies as a basis for risk assessment. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2015; 11:1285-98. [PMID: 25735266 DOI: 10.1016/j.nano.2015.02.006] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/25/2014] [Accepted: 12/03/2014] [Indexed: 12/28/2022]
Abstract
The objective of the Part II analysis was to evaluate animal and in vitro toxicology studies of CoCr particles with respect to their physicochemistry and dose relevance to metal-on-metal (MoM) implant patients as derived from Part I. In the various toxicology studies, physicochemical characteristics were infrequently considered and administered doses were orders of magnitude higher than what occurs in patients. Co was consistently shown to rapidly release from CoCr particles for distribution and elimination from the body. CoCr micron sized particles appear more biopersistent in vivo resulting in inflammatory responses that are not seen with similar mass concentrations of nanoparticles. We conclude, that in an attempt to obtain data for a complete risk assessment, future studies need to focus on physicochemical characteristics of nano and micron sized particles and on doses and dose metrics relevant to those generated in patients or in properly conducted hip simulator studies.
Collapse
Affiliation(s)
| | | | | | | | | | - Günter Oberdörster
- University of Rochester, Department of Environmental Medicine, Rochester, NY, USA
| |
Collapse
|
6
|
Rainsford KD, Haynes DR. Professor Barrie Vernon-Roberts, AO, MD, BSc, PhD, FRCPath, FRCPA, FAOrthA (Hon), FRS.SA. Inflammopharmacology 2013; 21:269-77. [PMID: 23824627 DOI: 10.1007/s10787-013-0176-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2013] [Accepted: 06/11/2013] [Indexed: 11/25/2022]
Abstract
This issue of Inflammopharmacology contains papers that have been submitted to commemorate the life and work of Professor Barrie Vernon-Roberts, an outstanding clinical scientist in the field of bone pathology and its pharmacological regulation. This review briefly summarizes his major works and achievements as well as a list of his publications.
Collapse
|
7
|
Kranz I, Gonzalez JB, Dörfel I, Gemeinert M, Griepentrog M, Klaffke D, Knabe C, Österle W, Gross U. Biological response to micron- and nanometer-sized particles known as potential wear products from artificial hip joints: Part II: Reaction of murine macrophages to corundum particles of different size distributions. J Biomed Mater Res A 2009; 89:390-401. [DOI: 10.1002/jbm.a.32121] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
8
|
Bennett D, Humphreys L, O’Brien S, Kelly C, Orr J, Beverland D. Wear paths produced by individual hip-replacement patients—A large-scale, long-term follow-up study. J Biomech 2008; 41:2474-82. [DOI: 10.1016/j.jbiomech.2008.05.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2007] [Revised: 05/08/2008] [Accepted: 05/14/2008] [Indexed: 12/28/2022]
|
9
|
Schuh A, Uter W, Kachler W, Göske J, Zeiler G, Lill C. Comparative surface examinations on corund blasted titanium implants and explants in total hip arthroplasty. Arch Orthop Trauma Surg 2005; 125:676-82. [PMID: 16189687 DOI: 10.1007/s00402-005-0050-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2004] [Indexed: 02/09/2023]
Abstract
INTRODUCTION Blasting techniques using corundum to create rough surfaces are used in many different processes for the surface treatment of hip implants. Recent evidence points an association between residual particles and early loosenings in the sense of third-body wear. MATERIALS AND METHOD The surfaces of five unused, original-packaged CLS stems and ARR-Titan supporting rings, respectively, were compared with five explanted CLS stems and ARR-Titan supporting rings. RESULTS The surface of the ARR-Titan supporting rings was adhered to Al2O3 particles at 23.2+/-2.5% on the implants and 12.3+/-3.0% on the explants (P < 0.0001). For the CLS stem, the surface to which Al2O3 particles adhered was 16.4+/-2.2 % on the implants, whereas the surface to which Al2O3 particles adhered was 12.4+/-3.3% on the explants (P = 0.0275). DISCUSSION The results of this study show that corundum particles can be found to cover a high percentage on rough-blasted titanium surfaces of ready-to-use devices. In contrast, this contamination is significantly less on the explants treated in an identical fashion prior to implantation.
Collapse
|
10
|
Nizard R, Sedel L, Hannouche D, Hamadouche M, Bizot P. Alumina pairing in total hip replacement. ACTA ACUST UNITED AC 2005; 87:755-8. [PMID: 15911653 DOI: 10.1302/0301-620x.87b6.16150] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- R Nizard
- Department of Orthopaedic Surgery, Hôpital Lariboisière, Assistance Publique des Hôpitaux de Paris, 2 Rue A. Paré, 75010 Paris, France.
| | | | | | | | | |
Collapse
|
11
|
O'Connor DT, Choi MG, Kwon SY, Paul Sung KL. New insight into the mechanism of hip prosthesis loosening: effect of titanium debris size on osteoblast function. J Orthop Res 2004; 22:229-36. [PMID: 15013079 DOI: 10.1016/s0736-0266(03)00167-0] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2002] [Accepted: 07/08/2003] [Indexed: 02/04/2023]
Abstract
The incidence of rheumatoid arthritis and osteoarthritis is on the rise due to our expanding elderly population. Total joint arthroplasty is the most successful, prevalent treatment modality for these and other degenerative hip conditions. Despite the wide array of prosthetic devices commercially available, hip prostheses share a common problem with a gradual and then accelerating loss of bone tissue and bone-implant interface integrity, followed by implant instability and loosening. Implant failure is largely the result of inevitable wear of the device and generation of wear debris. To provide information for the development of improved prosthetic wear characteristics, we examined the effects of size-separated titanium particles on bone forming cell populations. We demonstrate unequivocally that particle size is a critical factor in the function, proliferation, and viability of bone-forming osteoblasts in vitro. In addition, we have elucidated the time-dependent distribution of the phagocytosed particles within the osteoblast, indicating an accumulation of particles in the perinuclear area of the affected cells. The report finds that particle size is a critical factor in changes in the bone formation-related functions of osteoblasts exposed to simulate wear debris, and that 1.5-4 microm titanium particles have the greatest effect on osteoblast proliferation and viability in vitro. The size of titanium particles generated through wear of a prosthetic device may be an important consideration in the development of superior implant technology.
Collapse
Affiliation(s)
- Daniel T O'Connor
- Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0412, USA
| | | | | | | |
Collapse
|
12
|
Abstract
As early as 1956, laboratory investigations into the carcinogenicity of modern dental and orthopaedic alloys were undertaken. Such studies were prompted by the observation that workers, particularly in nickel and chromate refining, had increased risks of nasal and lung tumors. For the past 25 years, sporadic case reports have documented the development of malignant neoplasms proximate to an orthopaedic implant. Although the results of epidemiologic studies have not shown an excessive number of tumors in patients receiving stainless steel or superalloy implants, the possibility of carcinogenesis, given the corrosive environment in which metal implants exist, has prompted ongoing laboratory studies. Leaching of metal ions from implants, the synovial processing of metallic wear debris, and the effects of exposure to intraarticular metal particles have been the subjects of numerous laboratory studies. The results of these studies are summarized and recommended parameters for future laboratory investigations are given.
Collapse
Affiliation(s)
- C G Lewis
- Department of Orthopaedic Surgery, University of Connecticut Health Center, Farmington, CT, USA
| | | |
Collapse
|
13
|
Abstract
The literature on animal and cellular models used to study the response to cobalt chrome alloy implants and wear and corrosion products is reviewed. Animal studies show that in solid form cobalt chrome alloy is relatively well tolerated. Injections of large numbers of particles in a single bolus lead to acute inflammation and necrosis, followed by a chronic inflammatory response. Macrophages are the predominant cell type and may persist in the tissues for years. Long term studies have failed to confirm the induction of tumors. In vitro studies confirm the toxic effects of cobalt chrome alloy corrosion products and wear particles, especially cobalt, and show that intracellular corrosion is an important mechanism for early release of cobalt ions. In vitro studies show that cobalt chrome alloy particles induce the release of inflammatory mediators from macrophages before causing cell death. These mediators have significant effects on osteoblastlike cells, as well as inducing bone resorption. Variations in the cell types, implantation site, and characteristics of the particles used in experimental models make interpretation of the results difficult. Standardized methods to control for size, shape, and number of particles for testing are proposed. It is important that in vitro and in vivo findings not be taken in isolation, but be compared with the results of human studies.
Collapse
Affiliation(s)
- D W Howie
- Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Australia
| | | | | | | |
Collapse
|
14
|
Granchi D, Ciapetti G, Savarino L, Cavedagna D, Donati ME, Pizzoferrato A. Assessment of metal extract toxicity on human lymphocytes cultured in vitro. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 1996; 31:183-91. [PMID: 8731206 DOI: 10.1002/(sici)1097-4636(199606)31:2<183::aid-jbm4>3.0.co;2-j] [Citation(s) in RCA: 52] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
In this study the toxic effects of chromium, nickel, and cobalt extracts on in vitro cultured lymphocytes were evaluated. Graphite furnace atomic absorption spectrometry was used to measure the ion concentration. After serial dilution of the extracts, the viability of lymphocytes at 24, 48, and 72 h was estimated by flow cytometry, including propidium iodide staining and light scatter property assessment, and by MTT reduction test. The results of the investigation allowed us to conclude that 1) standardization of the procedure for preparing extracts is fundamental to obtaining repeatability of results; 2) the toxicity of an extract cannot be evaluated with a single viability assay; a combination of functional and structural tests is required; 3) when methods based on enzymatic reactions are performed, e.g. MTT test, it is advisable to replace the extract containing metal ions with fresh medium in order to avoid any interference with viability testing; 4) the amount of Co and Ni in the extract is similar, but the Cr release is very poor; 5) the lower toxicity of Cr extract probably is due to the lower ion concentration; 6) the assessment of 50% cytotoxic concentration (TC50) allows quantification of materials toxicity and comparison of various metals; and 7) the determination of a noncytotoxic concentration, i.e., a concentration lower than TC10, is required for subsequent investigation of cell functions because such studies can be carried out only on viable cell population.
Collapse
Affiliation(s)
- D Granchi
- Laboratory for Biocompatibility Research on Implant Materials, Istituti Ortopedici Rizzoli, Bologna, Italy
| | | | | | | | | | | |
Collapse
|
15
|
Abstract
A literature review of wear debris is presented. Included are debris retrieved at revision of total joint replacement and at autopsy, as well as debris produced in vitro in wear testers and joint simulators or otherwise fabricated for biological experiments. Observations of wear debris in vivo and in vitro are classified in tabular form according to material type, origin, size, shape and color. Polymer particles, most commonly ultra-high molecular weight polyethylene (UHMWPE), exhibit the largest size range and appear as granules, splinters or flakes, while ceramic particles possess the smallest size range and have a granular structure. Metal particles seen in vivo and in vitro, whether from cobalt-chromium alloys or, less frequently, other alloys, form granular or needle-like shapes and generally are smaller than polymer particles but larger than ceramic particles. Particles generated in joint simulators resemble the size and shape of in vivo wear particles from total joint replacement (TJR) retrieved at revision or autopsy. However, particles prepared in vitro, whether in simulators or by other means, do not consistently resemble wear debris particles from TJR.
Collapse
Affiliation(s)
- J A Savio
- Department of Bioengineering, Clemson University, SC 29634
| | | | | |
Collapse
|
16
|
Rogers SD, Pearcy MJ, Hay SJ, Haynes DR, Bramley A, Howie DW. A method for production and characterization of metal prosthesis wear particles. J Orthop Res 1993; 11:856-64. [PMID: 8283331 DOI: 10.1002/jor.1100110612] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The wear of joint prostheses generates wear particles that produce an inflammatory response in the surrounding tissues and may contribute to bone resorption resulting in prosthetic loosening. Although the effects of particles produced from prosthetic materials have been studied extensively in vitro and in vivo, little attention has been paid to the standardisation of methods for the generation and characterization of these particles. This paper describes a reproducible method for generation of metal particles by the abrasive shaking of joint replacement components. Particular attention was given to the production of metal particles that closely resembled particles found around solid and loose human prostheses. To achieve this, particle size, size distribution, chemical composition, and shape were characterized. Particles that were 0.5-3.0 microns in diameter were isolated by differential sedimentation, and the distribution of particle sizes was determined with use of a Coulter Multisizer. Chemical composition was measured by atomic absorption spectrophotometry, and transmission electron microscopy was used to characterize particle shape. The techniques were shown to be reproducible, since there was little variation between batches over a lengthy time period. These or similar methods of particle production and characterization should be an essential part of future in vitro and in vivo studies of wear particles.
Collapse
Affiliation(s)
- S D Rogers
- Department of Orthopaedic Surgery and Trauma, Royal Adelaide Hospital, Australia
| | | | | | | | | | | |
Collapse
|
17
|
Abstract
While it is known that dental implants can 'work'--the success of the Branemark 'osseointegrated' implant is a prime example--implants can also fail. The challenge is to develop a basic science understanding of all aspects which contribute to implant performance. In designing a successful dental implant, the main objective is to ensure that the implant can support biting forces and deliver them safely to interfacial tissues over the long term. Biomechanics are central in this design problem. Key topics include: (1) the nature of the biting forces on the implants; (2) how the biting forces are transferred to the interfacial tissues; (3) how the interfacial tissues react, biologically, to stress transfer conditions. For biting forces on dental implants, the basic problem is to determine the in-vivo loading components on implants in various prosthetic situations, e.g. for implants acting as single tooth replacements or as multiple supports for loaded bridgework. Significant progress has been made; several theoretical models have been presented for determining the partitioning of forces among dental implants supporting bridgework. However, more work will be needed to clarify how well these models match reality. Interfacial stress transfer and interfacial biology represent more difficult, interrelated problems. One problem is that the multitude of different shapes, sizes, materials, surgical sites and animal models for dental implants has precluded any generally accepted rules for biologically 'favorable' vs 'unfavorable' interfacial stress transfer conditions. While many engineering studies have shown that variables such as implant shape, elastic modulus, extent of bonding between implant and bone, etc., can affect the stress transfer conditions, the unresolved question is whether there is any biological significance to such differences. Recent research suggests that, at the very least, our search for a more detailed hypothesis regarding the relationship between interface mechanics and biology should take account of basic bone physiology, e.g. wound healing after implantation plus basic processes of bone modeling and remodeling.
Collapse
Affiliation(s)
- J B Brunski
- Department of Biomedical Engineering, Jonsson Engineering Center, Rensselaer Polytechnic Institute, Troy, NY 12180
| |
Collapse
|